Nyopdaget diabetes mellitus, hyperglykæmi eller forværring af allerede eksisterende diabetes mellitus er rapporteret hos patienter i behandling med proteasehæmmere.
New onset diabetes mellitus, hyperglycaemia or exacerbation of existing diabetes mellitus has been reported in patients receiving protease inhibitors.